Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Provided By PR Newswire
Last update: Jun 11, 2025
-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 --
-- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment --
Read more at prnewswire.com
